KLAC
61
-2
DHI
53
-3
LYB
46
-4
VMC
57
-3
TXN
50
-3
DE
53
8
LEN
55
-9
PFE
30
-3
DNB
50
-4
FMC
40
4
DHR
56
-4
VZ
47
2
WBA
24
-3
PRGO
44
-2
UNH
53
-3
ALLE
57
-7
BIIB
37
7
EQR
54
-2
UNP
40
-2
WAT
54
2
KLAC
61
-2
DHI
53
-3
LYB
46
-4
VMC
57
-3
TXN
50
-3
DE
53
8
LEN
55
-9
PFE
30
-3
DNB
50
-4
FMC
40
4
DHR
56
-4
VZ
47
2
WBA
24
-3
PRGO
44
-2
UNH
53
-3
ALLE
57
-7
BIIB
37
7
EQR
54
-2
UNP
40
-2
WAT
54
2
Financhill
Back

Global X S&P/TSX 60 Corp Cl ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
70

HXT.TO
Global X S&P/TSX 60 Corp Cl ETF

Last Price:
61.85
Seasonality Move:
0.73%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
70
Global X S&P/TSX 60 Corp Cl ETF (HXT.TO) is a Buy

Is Global X S&P/TSX 60 Corp Cl ETF a Buy, Sell or Hold?

  • The current Global X S&P/TSX 60 Corp Cl ETF [HXT.TO] share price is $61.85. The Score for HXT.TO is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • HXT.TO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

HXT.TO Stock Price Chart

What is Global X S&P/TSX 60 Corp Cl ETF's stock price today?

  • The Global X S&P/TSX 60 Corp Cl ETF share price today is $61.85
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HXT.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

HXT.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 69.06 Buy
Chaikin Money Flow: 229372 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (59.46 - 61.02) Buy
Bollinger Bands (100): (56.05 - 59.53) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

HXT.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 61.25 Buy
20-day SMA: 60.42 Buy
50-day SMA: 59.21 Buy
200-day SMA: 56.12 Buy
8-day EMA: 61.24 Buy
20-day EMA: 60.49 Buy
50-day EMA: 59.32 Buy
200-day EMA: 56.29 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Global X S&P/TSX 60 Corp Cl ETF Earnings Growth & HXT.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Global X S&P/TSX 60 Corp Cl ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):